[HTML][HTML] Next-generation sequencing for confronting virus pandemics

J Quer, S Colomer-Castell, C Campos, C Andrés… - Viruses, 2022 - mdpi.com
Virus pandemics have happened, are happening and will happen again. In recent decades,
the rate of zoonotic viral spillover into humans has accelerated, mirroring the expansion of …

[HTML][HTML] Mixed HCV infection and reinfection in people who inject drugs—impact on therapy

EB Cunningham, TL Applegate, AR Lloyd… - Nature reviews …, 2015 - nature.com
The majority of new and existing cases of HCV infection in high-income countries occur
among people who inject drugs (PWID). Ongoing high-risk behaviours can lead to HCV re …

[HTML][HTML] SARS-CoV-2 mutant spectra at different depth levels reveal an overwhelming abundance of low frequency mutations

B Martínez-González, ME Soria, L Vázquez-Sirvent… - Pathogens, 2022 - mdpi.com
Populations of RNA viruses are composed of complex and dynamic mixtures of variant
genomes that are termed mutant spectra or mutant clouds. This applies also to SARS-CoV …

Strategies for the improvement of HCV testing and diagnosis

S Chevaliez - Expert review of anti-infective therapy, 2019 - Taylor & Francis
Introduction: The improvement of number of people diagnosed with hepatitis C virus (HCV)
infection is crucial to reach the WHO objectives for eliminating viral hepatitis by 2030 …

Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure

Q Chen, C Perales, ME Soria, D García-Cehic… - Antiviral Research, 2020 - Elsevier
A percentage of hepatitis C virus (HCV)-infected patients fail direct acting antiviral (DAA)-
based treatment regimens, often because of drug resistance-associated substitutions (RAS) …

[HTML][HTML] Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes

S Ruta, C Cernescu - World journal of gastroenterology: WJG, 2015 - ncbi.nlm.nih.gov
Hepatitis C virus (HCV) genotypes' monitoring allows real-time insight into the dynamic
changes that occur in the global epidemiological picture of HCV infection. Intravenous drug …

Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant

C Perales, Q Chen, ME Soria, J Gregori… - Infection and drug …, 2018 - Taylor & Francis
Background: Controversy is ongoing about whether a minority mutant present at frequencies
below 15% may be clinically relevant and should be considered to guide treatment …

[HTML][HTML] Resistance of hepatitis C virus to inhibitors: complexity and clinical implications

C Perales, J Quer, J Gregori, JI Esteban, E Domingo - Viruses, 2015 - mdpi.com
Selection of inhibitor-resistant viral mutants is universal for viruses that display quasi-
species dynamics, and hepatitis C virus (HCV) is no exception. Here we review recent …

[HTML][HTML] Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virus

ME Soria, J Gregori, Q Chen, D García-Cehic… - BMC Infectious …, 2018 - Springer
Background Despite the high sustained virological response rates achieved with current
directly-acting antiviral agents (DAAs) against hepatitis C virus (HCV), around 5–10% of …

[HTML][HTML] Adaptive immune responses, immune escape and immune-mediated pathogenesis during HDV infection

V Oberhardt, M Hofmann, R Thimme… - Viruses, 2022 - mdpi.com
The hepatitis delta virus (HDV) is the smallest known human virus, yet it causes great harm
to patients co-infected with hepatitis B virus (HBV). As a satellite virus of HBV, HDV requires …